Figure 2.

In-vivo regulation of hepatic HMG-CoA reductase activity in cigarette smoke-exposed rats treated with FVBM extract, F18 bioactive compound and atorvastatin for 4 weeks of treatment.

^†Expressed as ratio of HMG-CoA to Mevalonate; lower the ratio higher the enzyme activity. ^*Values are mean   SD from liver homogenate of 5 rats in each group. Significantly different from N-C at ^ap < 0.001. Significantly different from S-C at ^ap < 0.001.